Fellowship · Camden, NJ
Sponsored by Cooper Medical School of Rowan University/Cooper University Hospital
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Christina Chu
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 134 citations · Christina Chu
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Gynecologic oncology · 2025 · 23 citations · David Warshal
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 83 citations · David Warshal
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278).
Gynecologic oncology · 2025 · 17 citations · David Warshal
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278).
Gynecologic oncology · 2025 · 10 citations ·
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.
Gynecologic oncology · 2025 · 11 citations · David Warshal
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 10 citations · David Warshal